From Name:
From Email:
To Name:
To Email:

Optional Message:

Liver transplant therapy given orphan drug status

from Healio

The FDA has granted orphan drug status to Conatus Pharmaceuticals for emricasan, a potential treatment for patients with chronic liver disease and acute exacerbations of chronic liver disease. The orally active caspase protease inhibitor is intended for liver transplant recipients with re-established fibrosis to delay the progression to cirrhosis and end-stage liver disease, the release said. It is designed to reduce activity of enzymes that mediate inflammation and apoptosis. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063